All podcasts

Rapid Detection of Sexually Transmitted Infections with Microfluidics - Dr. Anna Dixon

Sexually transmitted infections, once thought to be low frequency events, are staging a comeback. Dr. Anna Dixon of Binx Health describes how a nano-scale molecular biology reactions may be run rapidly and accurately on a point-of-care microfluidics chip. Early detection has significant benefits for patients, but also decrease health care costs.

Sep 17, 2022 by Dr. Kevin Folta in Talking Biotech

Apple podcasts link Google podcasts link Spotify podcasts link

Sexually transmitted infections like chlamydial and gonorrhea are making a comeback, especially with younger demographics. Part of the problem is the stigma of examination and testing. These are not trivial infections, and can result in more complicated syndromes, which could include sterility or issues reproductive health. Early, discrete, confidential detection is key. Today's guest is Dr. Anna Dixon. She's the Chief Technology Officer of Binx Health. Her company has devised a lab-on-a-chip solution that provides fast and accurate diagnosis of specific infections in thirty minutes. Providing non-invasive, rapid and accurate, point-of-care detection can have profound roles in advancing patient care, as well as decreasing the incidence of disease in a population.


Get your whole lab on the same page today.

Learn more